Struys M M, De Smet T, Versichelen L F, Van De Velde S, Van den Broecke R, Mortier E P
Department of Anesthesia, Ghent University Hospital, Belgium.
Anesthesiology. 2001 Jul;95(1):6-17. doi: 10.1097/00000542-200107000-00007.
This report describes a new closed-loop control system for propofol that uses the Bispectral Index (BIS) as the controlled variable in a patient-individualized, adaptive, model-based control system, and compares this system with manually controlled administration of propofol using hemodynamic and somatic changes to guide anesthesia.
Twenty female patients, American Society of Anesthesiologists physical status I or II, who were scheduled for gynecologic laparotomy were included to receive propofolremifentanil anesthesia. In group I, propofol was titrated using a BIS-guided, model-based, closed-loop system. The BIS target was set at 50. In group II, propofol was titrated using classical hemodynamic signs of (in)adequate anesthesia. Performance of control during induction and maintenance of anesthesia were compared between both groups using BIS as the controlled variable in group I and the reference variable in group II, and, conversely, the systolic blood pressure as the controlled variable in group II and the reference variable in group I. At the end of anesthesia, recovery profiles between groups were compared.
Although patients undergoing manual induction of anesthesia in group II at 300 ml/h reached a BIS level of 50 faster than patients undergoing open-loop, computer-controlled induction in group I, manual induction caused a more pronounced initial overshoot of the BIS target. This resulted in a more pronounced decrease in blood pressure in group II. During the maintenance phase, better control of BIS and systolic blood pressure was found in group I compared with group II. Recovery was faster in group I.
A closed-loop system for propofol administration using the BIS as a controlled variable together with a model-based controller is clinically acceptable during general anesthesia.
本报告描述了一种用于丙泊酚的新型闭环控制系统,该系统在患者个体化、自适应、基于模型的控制系统中使用脑电双频指数(BIS)作为控制变量,并将该系统与使用血流动力学和躯体变化来指导麻醉的丙泊酚手动给药方式进行比较。
纳入20例计划行妇科剖腹手术的美国麻醉医师协会身体状况I或II级的女性患者,接受丙泊酚-瑞芬太尼麻醉。在I组中,使用基于BIS引导、基于模型的闭环系统滴定丙泊酚。BIS目标设定为50。在II组中,使用麻醉(不)充分的经典血流动力学体征滴定丙泊酚。比较两组在麻醉诱导和维持期间的控制性能,I组以BIS作为控制变量,II组以BIS作为参考变量;反之,II组以收缩压作为控制变量,I组以收缩压作为参考变量。在麻醉结束时,比较两组之间的恢复情况。
尽管II组以300 ml/h手动诱导麻醉的患者比I组接受开环、计算机控制诱导的患者更快达到BIS水平50,但手动诱导导致BIS目标的初始过冲更明显。这导致II组血压下降更明显。在维持阶段,与II组相比,I组对BIS和收缩压的控制更好。I组恢复更快。
在全身麻醉期间,使用BIS作为控制变量并结合基于模型的控制器的丙泊酚给药闭环系统在临床上是可接受的。